Market Overview The global irritable bowel syndrome (IBS) treatment market was valued at USD 3.69 billion in 2023 and is expected to grow at a CAGR of 8.4% during the forecast period. The market includes a wide range of treatment options, such as pharmaceutical drugs (including antispasmodics, laxatives, anti-diarrheals, and probiotics), dietary supplements, and emerging therapies...